RxDoctor Payments Data

Christopher Peters, MD

Adult Reconstructive Orthopaedic Surgery · Salt Lake City, UTNPI 1407946023

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,833,207 of the $7,608,388 with a category attached, or 76.7%. Zimmer Biomet accounts for 99.7% of it on its own, with 3 other manufacturers making up the rest. Among adult reconstructive orthopaedic surgery clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,608,388in general payments, 2019–2025

Across 360 payments — averaging $21,134 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$7.6M
  • Smith+Nephew$20K
  • Synthes GmbH$5K
  • Stryker$384
$25,634in research payments, 2019–2025

Across 5 payments — averaging $5126.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$26K

What the payments were for

  • Royalty or licence$5,833,20777%
  • Consulting fees$1,443,85019%
  • Speaking & faculty fees$2,5000%
  • Travel & lodging$43,6021%
  • Food & beverage$6,6240%
  • Education$48,9191%
  • Other$229,6873%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet328$7,583,434
Smith+Nephew22$20,050
Synthes GmbH3$4,520
Stryker7$384

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,608,388 in reported general payments places this provider in the 90th percentile of 20 adult reconstructive orthopaedic surgery providers in Utah.

See all adult reconstructive orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$178,246
Medicare patients
232
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin11$10

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →